Form 8-K - Current report:
SEC Accession No. 0001079973-14-000327
Filing Date
2014-05-28
Accepted
2014-05-28 07:51:42
Documents
28
Period of Report
2014-05-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K appy_8k.htm 8-K 23670
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 20625
3 slide1.jpg GRAPHIC 40379
4 slide2.jpg GRAPHIC 138572
5 slide3.jpg GRAPHIC 53815
6 slide4.jpg GRAPHIC 54983
7 slide5.jpg GRAPHIC 48917
8 slide6.jpg GRAPHIC 71909
9 slide7.jpg GRAPHIC 73025
10 slide8.jpg GRAPHIC 65168
11 slide9.jpg GRAPHIC 53390
12 slide10.jpg GRAPHIC 54400
13 slide11.jpg GRAPHIC 61166
14 slide12.jpg GRAPHIC 52454
15 slide13.jpg GRAPHIC 55103
16 slide14.jpg GRAPHIC 81882
17 slide15.jpg GRAPHIC 69436
18 slide16.jpg GRAPHIC 70702
19 slide17.jpg GRAPHIC 55320
20 slide18.jpg GRAPHIC 63005
21 slide19.jpg GRAPHIC 69418
22 slide20.jpg GRAPHIC 57906
23 slide21.jpg GRAPHIC 83651
24 slide22.jpg GRAPHIC 56493
25 slide23.jpg GRAPHIC 46821
26 slide24.jpg GRAPHIC 125559
27 slide25.jpg GRAPHIC 53863
28 slide26.jpg GRAPHIC 58250
  Complete submission text file 0001079973-14-000327.txt   2412287
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33675 | Film No.: 14871359
SIC: 2835 In Vitro & In Vivo Diagnostic Substances